Drug Profile
Research programme: macrophage migration inhibitory factor therapies - Advanced Cancer Therapeutics
Alternative Names: 4-IPPLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator University of Louisville
- Developer Advanced Cancer Therapeutics
- Class Small molecules
- Mechanism of Action Macrophage migration inhibitory factor inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Autoimmune disorders; Cancer
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Autoimmune-disorders in USA
- 16 Jul 2016 No recent reports of development identified for preclinical development in Cancer in USA
- 07 Mar 2008 Preclinical trials in Autoimmune disorders in USA (unspecified route)